Previous studies have shown that FOXO3a plays a crucial role in inflammatory and autoimmune processes, and its upregulation alleviates symptoms by inhibiting the PI3K-AKT signaling pathway, a mechanism that helps reduce the severity of LN [39]. Here, FOXO3 is linked to lobular neoplasia.